Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment
Crossref DOI link: https://doi.org/10.1007/s00428-016-1903-3
Published Online: 2016-01-11
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Polónia, António
Leitão, Dina
Schmitt, Fernando
Text and Data Mining valid from 2016-01-11
